ClariPi Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • ClariPi's estimated annual revenue is currently $870k per year.(i)
  • ClariPi's estimated revenue per employee is $87,000

Employee Data

  • ClariPi has 10 Employees.(i)
  • ClariPi grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M11-8%N/AN/A
#2
$1.4M160%N/AN/A
#3
$1.4M1633%N/AN/A
#4
$0.6M8-27%N/AN/A
#5
$0.6M814%N/AN/A
#6
$7.2M5510%N/AN/A
#7
$2.5M25-43%N/AN/A
#8
$6.7M519%N/AN/A
#9
$8M615%N/AN/A
#10
$0.1M1-80%N/AN/A
Add Company

What Is ClariPi?

ClariPi is an AI company that offers innovative medical imaging solutions through deep-learning and AI technology to change the standards of patient safety, making it our number one priority to reduce harmful health risks. Our products help patients get CT scans with radiation dose at virtually harmless level (1/10th of current practice) and yet produces high-quality images for diagnosis. [Our Key Products] * ClariCT.AI: provides powerful denoising and image clarity enabled by our signature AI-powered clarity engine. This product is to be paired with low-dose and ultra-low-dose CT scans to ensure the protection of patients and staff. * ClariPulmo: a fully automated AI-powered 3D reporting solution for emphysema and COVID-19 pneumonia. Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions despite strong image noise and varying scanning conditions. It is best suited for low-dose lung CT screenings. Ask us how this product can help with COVID-19. * ClariSIGMAM: a fully automated zero-click breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. * ClariOsteo: an AI-powered precision bone healthcare solution with low-dose CT images. It uses existing CT scans and automatically provides analysis reports on spine fractures and osteoporosis risks which is useful for prevention and treatment management. * ClariACE: an AI-powered augmented contrast enhancing solution for low-dose CECT images. Our powerful pre-trained deep learning model selectively boosts contrast agent components in CT images without increasing contrast agent doses for patients. It clearly and selectively enhances the contrast of iodine without increasing noise in CT images. Our representative can give you a quick demo of these products as well as detailed image comparisons if you are interested. Thank you!

keywords:N/A

N/A

Total Funding

10

Number of Employees

$870k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M10-72%N/A
#2
$0.9M10N/AN/A
#3
$2.4M10-17%N/A
#4
$1.7M12-8%N/A
#5
$1.2M14-39%N/A